Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.399 GBX | -0.09% | -9.76% | -70.24% |
May. 20 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
May. 20 | IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate | MT |
Business Summary
Sales per region
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +2.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 15-02-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 15-02-12 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 17-01-19 |
Director/Board Member | - | 19-12-17 | |
Brett Skelly
BRD | Director/Board Member | - | 21-09-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 221,709,789 | 136,845,642 ( 61.72 %) | 0 | 61.72 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-70.24% | 3.94M | |
-22.04% | 8.54B | |
+68.74% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-9.46% | 1.9B | |
-18.68% | 1.59B | |
-39.48% | 1.23B | |
+9.68% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- IQAI Stock
- Company IQ-AI Limited